News and features
Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
-547x410.jpg?sfvrsn=2c1d545c_2 "A high magnification image of ovarian clear cell carcinoma (photo: Nephron) 547x410")
How we’re commercialising a pioneering cancer drug
In advance of industry conference BIO-Europe, Henry French speaks to the Enterprise Unit’s Dr Toby Richardson about one of the most promising commercialisation opportunities in our partnering portfolio.
The ICR named UK’s top higher education institution for commercial earnings
The Institute of Cancer Research, London, is now the most successful higher education institution in the UK at earning invention income from its research.
New targeted cancer drug shows signs of effectiveness in first clinical trial
A new targeted cancer drug has a good safety profile and has led to responses in some patients with particular genetic characteristics in their tumours.
Pioneering imaging tech measures cell changes in melanoma
A cutting-edge form of non-invasive imaging technology can track the response of malignant melanoma cells to treatment, researchers have found.
Government minister Lord Prior visits The London Cancer Hub
Transport links in Sutton, and the potential for science to drive economic growth, were two of the themes of a visit by Government minister Lord Prior to The London Cancer Hub.
Cancer relapse linked to body’s own immune system
Cancer cells that survive after treatment may use the body’s own immune system to wake themselves up and fuel their growth, a new study shows.
Breakthrough for advanced head and neck cancer patients as nivolumab made available on the Cancer Drugs Fund
The immunotherapy nivolumab has today been made available on the Cancer Drugs Fund (CDF) for patients with head and neck cancer if the disease progresses within six months of receiving platinum chemotherapy.
New myeloma clinical trial launches with aim to transform treatment from one-size-fits-all approach
People with newly diagnosed high risk myeloma will be treated based on the results of genetic testing as part of a new UK-first clinical trial.
Quick, cheap genetic test could help prostate cancer treatment
Identifying which men with advanced prostate cancer will benefit from targeted treatments could be made easier with a quick and cost-effective test, researchers have found.
State of immune system linked to worse survival in biliary tract cancers
The state of the immune system in the area around a biliary tract cancer tumour may be a good indicator of whether the cancer is likely to return following surgery, researchers have found.
Overactive gene associated with more aggressive forms of bone marrow cancer myeloma
A gene which is overactive in some cases of myeloma has been linked, for the first time, with more aggressive forms of the disease.
Study splits incurable childhood brain tumours into 10 new diseases
Scientists have found that deadly childhood brain tumours are actually 10 different diseases that should each be diagnosed and treated based on their specific genetic faults.
